| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks
2 companies
Sinha Vikas is a Chief Financial Officer at SRRK, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 41 sales. Those positions are worth an estimated $31.2M at current prices.
Our model assigns Sinha Vikas a strong insider score of 83/100, based on 40 past trades. Over a 12-month horizon, 97.4% of those trades were profitable, with an average 12-month return of +60.5%.
Sinha Vikas's largest disclosed position is in SRRK as Chief Financial Officer, worth about $30.7M. The recent filings there lean toward selling, a net 27,165 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2022 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 1,432 | $5.21 | $7,467.16 | -0.2% | +87.2% | -37.9% | |
| Apr 20, 2022 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 1,162 | $6.68 | $7,767.16 | -0.1% | -17.9% | -39.5% | |
| Jan 20, 2022 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 6,450 | $8.75 | $56,454.27 | -0.7% | -26.4% | -38.2% |